Jianhua Sui

This inventor holds 15 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., The Brigham and Women's Hospital, Inc., Burnham Institute for Medical Research. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianhua Sui. Retrieved from https://idiyas.com/inventor/jianhua-sui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 8)

% Patents Active = 93.3

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 43(Granted Patents)

Location History:

Stoneham, MA (US) (2016 - 2019)
Boston, MA (US) (2010 - 2020)
Waltham, MA (US) (2015 - 2022)

Company Filing History:

13 out of 1,266

Dana-Farber-Cancer Institute Inc.

patents

4 out of 1,425

The Brigham and Women's Hospital, Inc.

patents

2 out of 55

Burnham Institute for Medical Research

The Bingham and Women's Hospital

patents

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11485774 - Anti-pre-S1 HBV antibodies (2022-11-01),

2. 10774134 - Conserved hemagglutinin epitope, antibodies to the epitope, and methods of use (2020-09-15),

3. 10604581 - Human monoclonal anti-PD-L1 antibodies and methods of use (2020-03-31),

4. 10584172 - Humanized monoclonal antibodies and methods of use (2020-03-10),

5. 10544205 - Anti-Pre-S1 HBV antibodies (2020-01-28),

6. 10179822 - Humanized monoclonal antibodies and methods of use (2019-01-15),

7. 9951122 - Antibodies against influenza virus and methods of use thereof (2018-04-24),

8. 9828434 - Human monoclonal anti-PD-L1 antibodies and methods of use (2017-11-28),

9. 9587028 - Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use (2017-03-07),

10. 9527924 - Humanized monoclonal antibodies and methods of use (2016-12-27),

11. 9441045 - Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use (2016-09-13),

12. 9416169 - Humanized monoclonal antibodies and methods of use (2016-08-16),

13. 8962806 - Humanized monoclonal antibodies and methods of use (2015-02-24),

14. 8329178 - Antibodies against CXCR4 and methods of use thereof (2012-12-11),

15. 7750123 - Antibodies against SARS-CoV and methods of use thereof (2010-07-06),

Title: The Innovative Journey of Jianhua Sui

Introduction: Jianhua Sui, a talented inventor based in Waltham, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Jianhua Sui's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Jianhua Sui has established himself as a leading figure in the tech industry, holding key positions in various renowned companies and research institutions. His innovative solutions have revolutionized multiple sectors, earning him recognition and accolades.

Collaborations: Jianhua Sui has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing. His partnerships have led to the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: Jianhua Sui's passion for innovation, coupled with his dedication to pushing the boundaries of technology, continues to inspire the next generation of inventors. His remarkable journey serves as a testament to the power of creativity and perseverance in driving meaningful change in the world.

Profile summary based on public USPTO records.